17505008 |
AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor
Fukuoka, K,
Yamada, Y,
Yanagihara, K,
Nishio, K,
Sasaki, H,
Kimura, H,
Takeda, M,
Tamura, T,
Komatsu, T,
Yokote, H,
Arao, T,
Saijo, N
|
Clin Cancer Res |
2007 |
18757403 |
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation
Pollock, PM,
Wellens, CL,
Goodfellow, PJ,
Gartside, MG,
Mallon, MA,
Powell, MA,
Byron, SA,
Keenan, JB
|
Cancer Res |
2008 |
11739186 |
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Doody, ML,
Demiroglu, A,
Carnicero, F,
Brody, JP,
Melo, JV,
Koduru, P,
Cross, NC,
Heath, C,
Hawson, G,
Taylor, K,
Steer, EJ,
Goldman, JM,
Reiter, A,
Rodwell, R,
Bentley, M,
Allen, SL
|
Blood |
2001 |
15448205 |
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
Gilliland, DG,
Cohen, S,
Huntly, B,
Galinsky, I,
Xiao, S,
Duclos, N,
Fabbro, D,
Kutok, JL,
Stone, RM,
Fletcher, JA,
Roesel, J,
Okabe, R,
Lee, BH,
Chen, J,
Banerji, L,
Adelsperger, J,
Wadleigh, M,
Williams, IR,
Deangelo, DJ,
Meyer, T,
Cohen, PS,
Griffin, JD,
Coburn, A
|
Proc Natl Acad Sci U S A |
2004 |
18381441 |
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival
Kunii, K,
Gorenstein, J,
Hatch, H,
Lutterbach, B,
Yashiro, M,
Davis, L,
Di Bacco, A,
Elbi, C
|
Cancer Res |
2008 |